ArticlePloS one2019

Single center experience on efficacy and safety of Aprepitant for preventing chemotherapy-induced nausea and vomiting (CINV) in pediatric Hodgkin Lymphoma.

Giovanna Giagnuolo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.